Literature DB >> 33875432

Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.

Karima Zarrouk1, Xiaojun Zhu2, Van Dung Pham2, Nathalie Goyette1, Jocelyne Piret1, Rong Shi2,3, Guy Boivin1.   

Abstract

Amino acid substitutions conferring resistance of herpes simplex virus 1 (HSV-1) and human cytomegalovirus (HCMV) to foscarnet (PFA) are located in the genes UL30 and UL54, respectively, encoding the DNA polymerase (pol). In this study, we analyzed the impact of substitutions located in helix K and region II that are involved in the conformational changes of the DNA pol. Theoretical substitutions were identified by sequences alignment of the helix K and region II of human herpesviruses (susceptible to PFA) and bacteriophages (resistant to PFA) and introduced in viral genomes by recombinant phenotyping. We characterized the susceptibility of HSV-1 and HCMV mutants to PFA. In UL30, the substitutions I619K (helix K), V715S, and A719T (both in region II) increased mean PFA 50% effective concentrations (EC50s) by 2.5-, 5.6-, and 2.0-fold, respectively, compared to the wild type (WT). In UL54, the substitution Q579I (helix K) conferred hypersusceptibility to PFA (0.17-fold change), whereas the substitutions Q697P, V715S, and A719T (all in region II) increased mean PFA EC50s by 3.8-, 2.8- and 2.5-fold, respectively, compared to the WT. These results were confirmed by enzymatic assays using recombinant DNA pol harboring these substitutions. Three-dimensional modeling suggests that substitutions conferring resistance/hypersusceptibility to PFA located in helix K and region II of UL30 and UL54 DNA pol favor an open/closed conformation of these enzymes, resulting in a lower/higher drug affinity for the proteins. Thus, this study shows that both regions of UL30 and UL54 DNA pol are involved in the conformational changes of these proteins and can influence the susceptibility of both viruses to PFA.

Entities:  

Keywords:  3D modeling; DNA polymerase; HCMV; HSV-1; NH2-terminal domain; drug resistance mechanisms; foscarnet; herpes simplex virus; human cytomegalovirus; palm domain; resistance

Mesh:

Substances:

Year:  2021        PMID: 33875432      PMCID: PMC8218610          DOI: 10.1128/AAC.00390-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

Review 1.  DNA polymerases: structural diversity and common mechanisms.

Authors:  T A Steitz
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

2.  Crystal structure of the herpes simplex virus 1 DNA polymerase.

Authors:  Shenping Liu; John D Knafels; Jeanne S Chang; Gregory A Waszak; Eric T Baldwin; Martin R Deibel; Darrell R Thomsen; Fred L Homa; Peter A Wells; Monica C Tory; Roger A Poorman; Hua Gao; Xiayang Qiu; Andrew P Seddon
Journal:  J Biol Chem       Date:  2006-04-24       Impact factor: 5.157

3.  Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.

Authors:  Karima Zarrouk; Van Dung Pham; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 4.  Antiviral drug resistance in herpesviruses other than cytomegalovirus.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Rev Med Virol       Date:  2014-03-07       Impact factor: 6.989

5.  Compilation, alignment, and phylogenetic relationships of DNA polymerases.

Authors:  D K Braithwaite; J Ito
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

6.  A cosmid-based system for constructing mutants of herpes simplex virus type 1.

Authors:  C Cunningham; A J Davison
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

Review 7.  Letermovir: First Global Approval.

Authors:  Esther S Kim
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

8.  A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.

Authors:  T Cihlar; M D Fuller; A S Mulato; J M Cherrington
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

9.  Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.

Authors:  Jocelyne Piret; Nathalie Goyette; Guy Boivin
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

Review 10.  Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase.

Authors:  D Topalis; S Gillemot; R Snoeck; G Andrei
Journal:  Nucleic Acids Res       Date:  2016-09-29       Impact factor: 16.971

View more
  1 in total

Review 1.  40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?

Authors:  Anna Majewska; Beata Mlynarczyk-Bonikowska
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.